Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study.
Autor: | Kim, Young, Sym, Sun, Baek, Min, Park, Inkeun, Hong, Junshik, Ahn, Hee, Park, Jinny, Cho, Eun, Lee, Woon, Chung, Min, Kim, Hyung-Sik, Lee, Jae, Shin, Dong, Kim, Young Saing, Sym, Sun Jin, Baek, Min Young, Ahn, Hee Kyung, Cho, Eun Kyung, Lee, Woon Ki, Lee, Jae Hoon |
---|---|
Předmět: |
TRASTUZUMAB
DRUG dosage HER2 gene STOMACH cancer treatment PILOT projects ANEMIA ANOREXIA nervosa ANTINEOPLASTIC agents CLINICAL trials COMPARATIVE studies DOSE-effect relationship in pharmacology FATIGUE (Physiology) LONGITUDINAL method RESEARCH methodology MEDICAL cooperation NAUSEA RESEARCH STOMACH tumors VOMITING EVALUATION research TREATMENT effectiveness KAPLAN-Meier estimator |
Zdroj: | Cancer Chemotherapy & Pharmacology; Dec2015, Vol. 76 Issue 6, p1267-1272, 6p |
Abstrakt: | |
Databáze: | Complementary Index |
Externí odkaz: |